Nuclear Medicine radiopharmaceuticals Stable Isotopes Market Report

2022-05-30 14:51:30 UTC | Healthcare & Pharmaceuticals Nuclear Medicine radiopharmaceuticals Stable Isotopes Market Report is expected to grow at CAGR XX% by 2028.

Nuclear Medicine radiopharmaceuticals Stable Isotopes Market Report was $XX Million in 2020 and is expected to reach $XX Billion by the forecasted period 2021 to 2028.

Increased application of radioisotopes, increased public awareness, usage of SPECT/CT and PET/CT (hybrid imaging) imaging scanners, and technological advancements are driving the growth of the nuclear medicine market. Additionally, growing need in emerging markets, production of radiopharmaceuticals from cyclotrons, effective diagnosis and treatments, emerging radioisotopes and replacement of old/traditional equipment are the opportunities that could drive the growth of the market of nuclear medicine. However, the high cost of radioisotopes, shorter half-life, shortage of skilled technicians, and radiotoxicity issues are restraining the market growth. Strict regulations, high capital investments, reactor shutdowns, and threats from traditional imaging techniques are hampering market expansion.

Download Free PDF and Avail free Sample Report here-
https://www.cspmarketresearch.com/download-sample.php?id=65268

NUCLEAR MEDICINE RADIOPHARMACEUTICALS STABLE ISOTOPES MARKET SCOPE
CSP research recently published a report titled "(Nuclear Medicine radiopharmaceuticals Stable Isotopes Market)" on the strength of the industry conjointly the} current and future trends that play a key role within the growth of the business. The report also highlights the drivers and barriers to growth. The report provides in-depth research and business growth insights. It examines necessary factors resembling value and offers future growth opportunities and forecasts supported their industry analysis. Throughout the study, researchers also study company profiles with details of the large players in the market today.

The market segments are [Modality (Diagnostics {SPECT (Technetium (Tc-99m), Thallium (Tl-201),Gallium (Ga-67), Iodine (I-123), Samarium (Sm-153), Xenon (Xe-133), Rhenium (Re-186)and Others); PET (Fluorodeoxyglucose (18F-FDG), Gallium (Ga-68), Rubidium (Rb-82)and Others}; SPECT Applications, PET Applications; Therapeutics Radiation Type(Beta-Radiation [Yttrium (Y-90), Iodine (I-131), Lutetium (Lu-177), Samarium (Sm-153),Rhenium (Re-186), Strontium (Sr-89), Erbium (Er-169) and Others], Alpha-Radiationand Brachytherapy[Iodine (I-125), Cesium (Cs-131), Iridium (Ir-192), Palladium (Pd-103)and Others) and Therapeutic Application); End Users (Hospitals, Diagnostic Centers,Ambulatory centers & Others); STABLE ISOTOPES: Isotopes (Carbon, Deuterium,Oxygen, Nitrogen, Sulphur & Others); Application (Diagnostics & therapy,Pharmaceuticals and Others)

COMPETITIVE LANDSCAPE
Global Nuclear Medicine radiopharmaceuticals Stable Isotopes Market report landscape includes company profiles with detailed data such as business overview, deals and specifications, key monetary metrics (total, gross and net), COVID19 impact analysis, SWOT analysis, market share, production and capacity (MW), key development activities, etc. for market makers are Bayer AG (Germany), GE Company (U.S.), Cardinal Health (U.S.), Jubilant Life science (India), Lantheus Medical Imaging (U.S.), Novartis, International AG (Advanced accelerator) (Switzerland), South African Nuclear, Energy Corporation (NTP Radioisotopes SOC Ltd) (South Africa), Siemens AG, (Germany) and Fujifilm Holding Corporation (Japan), Nihon Medi-Physics Co., Ltd. (Japan), Covidien PLC (U.S.), Fujifilm Corporation (Japan), ANSTO (Australia), and IBA S.A (Belgium), Curium Pharma(France), Perma-Fix, Environmental Services, Inc. (Perma Fix Medical SA) (Poland), Board of Radiation & Isotope Technology (India), Institute of Isotopes (Hungary), Isotopia Molecular Imaging Ltd. (Israel), Orano Med (Areva Med) (U.S.), Curium Pharma (France), Eckert & Ziegler Strahlen (Germany), IsoAid LLC (U.S.), Shine Medical Technologies, Inc (U.S.), Theragenics Corporation (U.S.), Isoray Medical Inc (U.S.)

Request for Customization-
https://www.cspmarketresearch.com/request-customization.php?id=65268

REGIONAL ANALYSIS
On the regional level presence, Nuclear Medicine radiopharmaceuticals Stable Isotopes Market segmented into. North America, Europe, Latin America, Asia-Pacific including China and Middle East & Africa. This report is covered into geographically, with sales, revenue, market share and rate of growth Nuclear Medicine radiopharmaceuticals Stable Isotopes Market in these regions.

The North America region generated the largest revenue from the stable isotopes market and is expected to grow at a high single-digit CAGR owing to increasing research activities and increasing applications in this region. Asia-Pacific holds the largest share in terms of investment in R&D is driving the stable isotopes market, but the high cost of stable isotopes is hampering the market in this region.

NUCLEAR MEDICINE RADIOPHARMACEUTICALS STABLE ISOTOPES MARKET SEGMENTS
On the basis of Modality
1. Diagnostics
2. SPECT (Technetium (Tc-99m)
3. Thallium (Tl-201)
4. Gallium (Ga-67)
5. Iodine (I-123)
6. Samarium (Sm-153)
7. Xenon (Xe-133)
8. Rhenium (Re-186)
9. Others
10. PET

11. (Fluorodeoxyglucose (18F-FDG)
12. Gallium (Ga-68)
13. Rubidium (Rb-82)
14. Others

On the basis of SPECT Applications
1. PET Applications
2. Therapeutics

On the basis of Radiation Type
1. Beta-Radiation [Yttrium (Y-90)
2. Iodine (I-131)
3. Lutetium (Lu-177)
4. Samarium (Sm-153)
5. Rhenium (Re-186)
6. Strontium (Sr-89)
7. Erbium (Er-169)
8. Others

On the basis of Alpha-Radiation and Brachytherapy
1. Iodine (I-125)
2. Cesium (Cs-131)
3. Iridium (Ir-192)
4. Palladium (Pd-103)
5. Others) and Therapeutic Application)

On the basis of STABLE ISOTOPES
1. Carbon
2. Deuterium
3. Oxygen
4. Nitrogen
5. Sulphur
6. Others

On the basis of Application
1. Diagnostics & Therapy
2. Pharmaceuticals
3. Others

On the basis of End Users
1. Hospitals
2. Diagnostic Centers
3. Ambulatory centers
4. Others

Avail Discount and ask for lucrative on Every Report
https://www.cspmarketresearch.com/ask-for-discount.php?id=65268

Major Players covered in the Report
1. Bayer AG (Germany)
2. GE Company (U.S.)
3. Cardinal Health (U.S.)
4. Jubilant Life science (India)
5. Lantheus Medical Imaging (U.S.)
6. Novartis, International AG (Advanced accelerator) (Switzerland)
7. South African Nuclear
8. Energy Corporation (NTP Radioisotopes SOC Ltd) (South Africa)
9. Siemens AG, (Germany)
10. Fujifilm Holding Corporation (Japan)
11. Nihon Medi-Physics Co., Ltd. (Japan)
12. Covidien PLC (U.S.)
13. Fujifilm Corporation (Japan)
14. ANSTO (Australia)
15. IBA S.A (Belgium)
16. Curium Pharma(France)
17. Perma-Fix, Environmental Services, Inc. (Perma Fix Medical SA) (Poland)
18. Board of Radiation & Isotope Technology (India)
19. Institute of Isotopes (Hungary)
20. Isotopia Molecular Imaging Ltd. (Israel)
21. Orano Med (Areva Med) (U.S.)
22. Curium Pharma (France)
23. Eckert & Ziegler Strahlen (Germany)
24. IsoAid LLC (U.S.)
25. Shine Medical Technologies, Inc (U.S.)
26. Theragenics Corporation (U.S.)
27. Isoray Medical Inc (U.S.)
* Listed companies in this report may vary in the final report subject to Name Change / Merger etc

GLOBAL NUCLEAR MEDICINE RADIOPHARMACEUTICALS STABLE ISOTOPES MARKET : BY REGIONAL ANALYSIS

1- North America
A. U.S.
B. Canada

2- Europe
A. Germany
B. U.K.
C. France
D. Italy
E. Spain
F. Rest of Europe

3- Asia Pacific
A. China
B. Japan
C. India
D. Rest of Asia Pacific

4- Latin America (LATAM)
A. Brazil
B. Mexico
C. Rest of Latin America (LATAM)

5- Middle East & Africa (MEA)
A. United Arab Emirates (UAE)
B. Saudi Arabia
C. Rest of Middle East & Africa (MEA)

You can buy direct this report with safe and secure payment Gateway
https://www.cspmarketresearch.com/checkout-report.php?id=65268

CSP Market Research analyst will gives you the thorough insightful information on Nuclear Medicine radiopharmaceuticals Stable Isotopes Market Size, competitive landscape is delivered i.e. Revenue Share Analysis (MN USD) by top key Players, Revenue Market Share (%) by key Players and further a qualitative analysis is made headed for market cognizance rate, product differentiation, and new entrants are also considered in heat map concentration

1. Historical data- 2018 to 2019
2. The base year for estimation- 2020
3. Forecast period- 2021 to 2028

OUR RESEARCH COVERS COMPETITORS
1. Company Profile
2. Main Business Information
3. SWOT Analysis
4. Sales, Revenue, Price, and Gross Margin
5. Market Share

TARGET AUDIENCE OF THE NUCLEAR MEDICINE RADIOPHARMACEUTICALS STABLE ISOTOPES MARKET IN THIS STUDY :

1. Key Consulting Companies & Advisors
2. Large, medium-sized, and small enterprises
3. Venture capitalists
4. Value-Added Resellers (VARs)
5. Third-party knowledge providers
6. Investment bankers
7. Investors

Do you have any query related to report speak to our Expert here and Read Full Report and Get Your PDF @
https://www.cspmarketresearch.com/report/nuclear-medicine-radiopharmaceuticals-stable-isotopes-market-65268

KEY REPORT DELIVERABLES IN THE REPORT NUCLEAR MEDICINE RADIOPHARMACEUTICALS STABLE ISOTOPES MARKET

1- What is the market size and growth rate?
2- Inclusive details of factors that will challenge the growth of the market pre & post-COVID-19 with 4 types of market recovery scenarios including V shaped recovery, U shaped recovery, L shaped recovery, and W shaped recovery?
3- What are the factors anticipated to drive the global Nuclear Medicine radiopharmaceuticals Stable Isotopes Market ?
4- What are trends, restraints, and challenges in the global Nuclear Medicine radiopharmaceuticals Stable Isotopes Market ?
5- Segment-wise analysis of global Nuclear Medicine radiopharmaceuticals Stable Isotopes Market ?
6- Regional as well as country level analysis for Nuclear Medicine radiopharmaceuticals Stable Isotopes Market ?
7- Who are the potential customers of the global Nuclear Medicine radiopharmaceuticals Stable Isotopes Market ?
8- Analysis of major strategies by key market players?
9- How are collaborations evolving in the market?
10- How is the competitive environment?
11- Which region has attractive investment proposition?
12- Competitive Landscape with numerous analysis including revenue analysis, geographic presence analysis, competitive benchmarking, company evaluation matrix, competitive landscape, market positioning analysis, key strategies analysis, and others?

Contact:
Raj
Sr. Corporate Manager
Phone : 91-8766590136
Email : info@westmarketreport.com